Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
Add more filters










Publication year range
1.
Cell Death Differ ; 23(6): 927-37, 2016 06.
Article in English | MEDLINE | ID: mdl-26868912

ABSTRACT

The skeletal muscle is an immunologically unique tissue. Leukocytes, virtually absent in physiological conditions, are quickly recruited into the tissue upon injury and persist during regeneration. Apoptosis, necrosis and autophagy coexist in the injured/regenerating muscles, including those of patients with neuromuscular disorders, such as inflammatory myopathies, dystrophies, metabolic and mitochondrial myopathies and drug-induced myopathies. Macrophages are able to alter their function in response to microenvironment conditions and as a consequence coordinate changes within the tissue from the early injury throughout regeneration and eventual healing, and regulate the activation and the function of stem cells. Early after injury, classically activated macrophages ('M1') dominate the picture. Alternatively activated M2 macrophages predominate during resolution phases and regulate the termination of the inflammatory responses. The dynamic M1/M2 transition is increasingly felt to be the key to the homeostasis of the muscle. Recognition and clearance of debris originating from damaged myofibers and from dying stem/progenitor cells, stromal cells and leukocytes are fundamental actions of macrophages. Clearance of apoptotic cells and M1/M2 transition are causally connected and represent limiting steps for muscle healing. The accumulation of apoptotic cells, which reflects their defective clearance, has been demonstrated in various tissues to prompt autoimmunity against intracellular autoantigens. In the muscle, in the presence of type I interferon, apoptotic myoblasts indeed cause the production of autoantibodies, lymphocyte infiltration and continuous cycles of muscle injury and regeneration, mimicking human inflammatory myopathies. The clearance of apoptotic cells thus modulates the homeostatic response of the skeletal muscle to injury. Conversely, defects in the process may have deleterious local effects, guiding maladaptive tissue remodeling with collagen and fat accumulation and promoting autoimmunity itself. There is strong promise for novel treatments based on new knowledge of cell death, clearance and immunity in the muscle.


Subject(s)
Apoptosis , Muscle, Skeletal/physiology , Animals , Autoantigens/immunology , Autoantigens/metabolism , Autoimmunity , Humans , Inflammation , Macrophages/immunology , Macrophages/metabolism , Muscle, Skeletal/immunology , Muscle, Skeletal/injuries , Regeneration/physiology , T-Lymphocytes/immunology , T-Lymphocytes/metabolism
2.
Cancer Res ; 61(7): 3092-5, 2001 Apr 01.
Article in English | MEDLINE | ID: mdl-11306492

ABSTRACT

T lymphocytes recognizing tumor antigens eventually undergo anergy or Fas-mediated death. V gamma9/V delta2+ T cells recognize poorly characterized ligand moieties on human B-cell lymphomas. Here we show that gammadelta T cells, a model for the study of activation-induced apoptosis, activate on repeated in vitro antigen-recognition caspase 3 and 8 and dramatically down-regulate their cytotoxic and secretory function. Caspase hindrance enhanced gammadelta T cell survival and sustained the killing of neoplastic cells and the release of IFN-gamma and tumor necrosis factor alpha. Caspases of tumor-specific T cells represent a candidate target to complement adoptive immunotherapy strategies.


Subject(s)
Caspase Inhibitors , Lymphoma/immunology , Receptors, Antigen, T-Cell, gamma-delta/immunology , T-Lymphocytes, Cytotoxic/immunology , Antigens, Neoplasm/immunology , Caspase 3 , Caspase 8 , Caspase 9 , Caspases/immunology , Cell Communication , Enzyme Activation , Humans , Lymphocyte Activation/immunology , Lymphoma/pathology
3.
J Neuroimmunol ; 114(1-2): 213-9, 2001 Mar 01.
Article in English | MEDLINE | ID: mdl-11240034

ABSTRACT

Increased titers of IgM anti-GM1 antibodies are present in some patients with Lower Motor Neuron Disease (LMND) or Motor Neuropathy (MN), but their pathogenic role and the mechanism of action are unclear. Previous studies have shown that the B subunit of Cholera Toxin (CT), which binds and crosslinks ganglioside GM1, modulate intracellular calcium in murine neuroblastoma cells via the activation of L-type voltage-dependent calcium channels (VGCC). Therefore, using a fluorimetric approach, we have examined the hypothesis that the pentameric IgM anti-GM1 antibodies, could similarly alter calcium concentration in N18 neuroblastoma cells. Sera with human IgM anti-GM1 antibodies were obtained from 5 patients with LMND and 2 patients with MN. Human IgG anti-GM1, IgM anti-Myelin Associated Glycoprotein (MAG), IgM anti-sulfatide antibodies and lectin peanut agglutinin (PNA), that recognizes specifically the Gal(betal-3)GalNAc epitope, were used as control sera. Direct application of either human IgM anti-GM1 antibodies or the B subunit of CT to N18 neuroblastoma cells induced a sustained influx of manganese ions, as indicated by a quench of the intracellular fura-2 fluorescence. Furthermore, the dihydropyridine L-type channel antagonists completely inhibited the manganese influx, suggesting that it is due to activation of an L-type VGCC. The magnitude of the influx was correlated with antibody titers. None of human IgG anti-GM1, IgM anti-MAG, IgM anti-sulfatide antibodies or PNA induce an ion influx, pointing to the selective participation of the pentameric IgM isotype of anti-GM1 in the modulation of L-type calcium channels opening. Given that L-type calcium channels are present on motor neurons, the modulation of L-type calcium channels by IgM GM1 antisera may have important implications in diseases such as LMND and MN.


Subject(s)
Autoantibodies/blood , Calcium/metabolism , G(M1) Ganglioside/immunology , Homeostasis/immunology , Immunoglobulin M/blood , Neurons/immunology , Adult , Calcium Channels/metabolism , Cholera Toxin , Humans , Immunoglobulin G/blood , Middle Aged , Motor Neuron Disease/immunology , Motor Neuron Disease/metabolism , Neuroblastoma , Neurons/metabolism , Tumor Cells, Cultured
4.
Free Radic Biol Med ; 29(8): 783-9, 2000 Oct 15.
Article in English | MEDLINE | ID: mdl-11053780

ABSTRACT

A short-term exposure of PC12 cells to tert-butylhydroperoxide promotes a rapid oxidation of dihydrorhodamine sensitive to nitric oxide synthase inhibitors and peroxynitrite scavengers. This response was not directly caused by peroxynitrite, but rather appeared to be mediated by peroxynitrite-dependent activation of phospholipase A(2). The following lines of evidence support this inference: (i) the peroxynitrite-dependent dihydrorhodamine fluorescence response was blunted by low concentrations of two structurally unrelated phospholipase A(2) inhibitors; (ii) under similar conditions, the phospholipase A(2) inhibitors prevented release of arachidonic acid; (iii) low levels of arachidonic acid restored the dihydrorhodamine fluorescence response in nitric oxide synthase- as well as phospholipase A(2)-inhibited cells; (iv) the dihydrorhodamine fluorescence response induced by authentic peroxynitrite was also blunted by phospholipase A(2) inhibitors and restored upon addition of reagent arachidonic acid. We conclude that endogenous, or exogenous, peroxynitrite does not directly oxidize dihydrorhodamine in intact cells. Rather, peroxynitrite appears to act as a signalling molecule promoting release of arachidonic acid, which in turn leads to formation of species causing the dihydrorhodamine fluorescence response.


Subject(s)
Nitrates/metabolism , Nitrates/toxicity , Phospholipases A/metabolism , Animals , Arachidonic Acid/metabolism , Arachidonic Acid/pharmacology , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacology , Fluorescent Dyes , Microscopy, Confocal , Oxidants/metabolism , Oxidants/toxicity , PC12 Cells , Phospholipases A/antagonists & inhibitors , Rats , Reactive Oxygen Species/metabolism , Rhodamines , tert-Butylhydroperoxide/toxicity
6.
J Neurosci ; 20(12): 4398-404, 2000 Jun 15.
Article in English | MEDLINE | ID: mdl-10844008

ABSTRACT

Broad spectrum caspase inhibitors have been found to reduce neurodegeneration caused by cerebral ischemia. We studied whether blockade of group I caspases, mainly caspase-1, using the inhibitor Ac-YVAD.cmk reduced infarct volume and produced prolonged neuroprotection. Ac-YVAD.cmk (300 ng/rat) was injected intracerebroventricularly 10 min after permanent middle cerebral artery occlusion in the rat. Drug treatment induced a significant reduction of infarct volume not only 24 hr after ischemia (total damage, percentage of hemisphere volume: control, 41.1 +/- 2.3%; treated, 26.5 +/- 2.1%; p < 0.05) but also 6 d later (total damage: control, 30.6 +/- 2.2%; treated, 23.0 +/- 2.2%; p < 0.05). Ac-YVAD. cmk treatment resulted in a reduction not only of caspase-1 (control, 100 +/- 20.3%; treated, 3.4 +/- 10.4%; p < 0.01) but also of caspase-3 (control, 100 +/- 30.3%; treated, 13.2 +/- 9.5%; p < 0.05) activity at 24 hr and led to a parallel decrease of apoptosis as measured by nucleosome quantitation (control, 100 +/- 11.8%; treated, 47 +/- 5.9%; p < 0.05). Six days after treatment no differences in these parameters could be detected between control and treated animals. Likewise, brain levels of the proinflammatory cytokines IL-1beta and TNF-alpha were reduced at 24 hr (39.5 +/- 23.7 and 51.9 +/- 10.3% of control, respectively) but not at 6 d. Other cytokines, IL-10, MCP-1, MIP-2, and the gaseous mediator nitric oxide, were not modified by the treatment. These findings indicate that blockade of caspase-1-like activity induces a long-lasting neuroprotective effect that, in our experimental conditions, takes place in the early stages of damage progression. Finally, this effect is achieved by interfering with both apoptotic and inflammatory mechanisms.


Subject(s)
Amino Acid Chloromethyl Ketones/pharmacology , Apoptosis/drug effects , Caspase Inhibitors , Cerebral Cortex/pathology , Cerebral Infarction/prevention & control , Cysteine Proteinase Inhibitors/pharmacology , Cytokines/biosynthesis , Ischemic Attack, Transient/physiopathology , Neuroprotective Agents/pharmacology , Amino Acid Chloromethyl Ketones/administration & dosage , Animals , Cerebral Cortex/drug effects , Cerebral Cortex/immunology , Cerebral Infarction/pathology , Cerebral Infarction/physiopathology , Chemokine CCL2/biosynthesis , Chemokine CXCL2 , In Situ Nick-End Labeling , Inflammation , Injections, Intraventricular , Interleukin-1/biosynthesis , Interleukin-10/biosynthesis , Ischemic Attack, Transient/pathology , Male , Monokines/biosynthesis , Nucleosomes/drug effects , Nucleosomes/pathology , Rats , Rats, Sprague-Dawley , Time Factors , Tumor Necrosis Factor-alpha/biosynthesis
7.
Proc Natl Acad Sci U S A ; 97(10): 5480-5, 2000 May 09.
Article in English | MEDLINE | ID: mdl-10792026

ABSTRACT

Apoptosis triggered by death receptors proceeds after defined signal-transduction pathways. Whether signaling at the receptor level is regulated by intracellular messengers is still unknown. We have investigated the role of two messengers, ceramide and nitric oxide (NO), on the apoptotic pathway activated in human monocytic U937 cells by tumor necrosis factor-alpha (TNF-alpha) working at its p55 receptor. Two transduction events, the receptor recruitment of the adapter protein, TRADD, and the activation of the initiator caspase, caspase 8, were investigated. When administered alone, neither of the messengers had any effect on these events. In combination with TNF-alpha, however, ceramide potentiated, whereas NO inhibited, TNF-alpha-induced TRADD recruitment and caspase 8 activity. The effect of NO, which was cGMP-dependent, was due to inhibition of the TNF-alpha-induced generation of ceramide. Our results identify a mechanism of regulation of a signal-transduction pathway activated by death receptors.


Subject(s)
Apoptosis/physiology , Ceramides/metabolism , Nitric Oxide/physiology , Penicillamine/analogs & derivatives , Tumor Necrosis Factor-alpha/pharmacology , Antigens, CD/physiology , Apoptosis/drug effects , Caspase 8 , Caspase 9 , Caspases/metabolism , Cyclic GMP/analogs & derivatives , Cyclic GMP/pharmacology , Cyclic GMP/physiology , Enzyme Inhibitors/pharmacology , Humans , Kinetics , Nitric Oxide Donors/pharmacology , Oxadiazoles/pharmacology , Penicillamine/pharmacology , Proteins/metabolism , Quinoxalines/pharmacology , Receptors, Tumor Necrosis Factor/physiology , Receptors, Tumor Necrosis Factor, Type I , S-Nitroso-N-Acetylpenicillamine , Second Messenger Systems , Signal Transduction , Sphingosine/analogs & derivatives , Sphingosine/pharmacology , TNF Receptor-Associated Factor 1 , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Tumor Necrosis Factor-alpha/pharmacokinetics , U937 Cells
8.
J Neurosci ; 20(10): 3705-13, 2000 May 15.
Article in English | MEDLINE | ID: mdl-10804212

ABSTRACT

Expansion of a polyglutamine sequence in the N terminus of huntingtin is the gain-of-function event that causes Huntington's disease. This mutation affects primarily the medium-size spiny neurons of the striatum. Huntingtin is expressed in many neuronal and non-neuronal cell types, implying a more general function for the wild-type protein. Here we report that wild-type huntingtin acts by protecting CNS cells from a variety of apoptotic stimuli, including serum withdrawal, death receptors, and pro-apoptotic Bcl-2 homologs. This protection may take place at the level of caspase-9 activation. The full-length protein also modulates the toxicity of the poly-Q expansion. Cells expressing full-length mutant protein are susceptible to fewer death stimuli than cells expressing truncated mutant huntingtin.


Subject(s)
Apoptosis/physiology , Caspases/metabolism , Nerve Tissue Proteins/genetics , Neurons/cytology , Neurons/enzymology , Nuclear Proteins/genetics , Animals , Caspase 3 , Caspase 9 , Cell Line, Transformed , Cell Survival/physiology , Cerebral Cortex/cytology , Corpus Striatum/cytology , Gene Expression Regulation, Enzymologic , In Situ Nick-End Labeling , Mutagenesis/physiology , Neurons/chemistry , Promoter Regions, Genetic/physiology , Proto-Oncogene Proteins c-bcl-2/genetics , Transfection , bcl-X Protein
9.
Eur J Neurosci ; 12(1): 145-54, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10651869

ABSTRACT

A short-term exposure to tert-butylhydroperoxide (tB-OOH) promoted a concentration-dependent formation of DNA single-strand breaks in PC12 cells. These events were paralleled by an increase in the cytosolic concentration of Ca2+ that was in part cleared by the mitochondria. Unlike the extent of Ca2+ mobilization and/or mitochondrial Ca2+ clearance, the DNA strand scission evoked by the hydroperoxide was markedly reduced by the nitric oxide (NO) scavenger 2-phenyl-4,4,5,5-tetramethylimidazolin-1-oxyl-3-oxide (PTIO) or by the NO synthase inhibitor N-nitro-L-arginine methylester (L-NAME). Inhibitors of electron transport (rotenone and myxothiazol), ruthenium red (RR, a polycation which inhibits the calcium uniporter of mitochondria), or peroxynitrite scavengers (Trolox and L-methionine) were as effective as PTIO or L-NAME in inhibiting the DNA-damaging response mediated by tB-OOH. Rotenone, RR or peroxynitrite scavengers did not further reduce the residual DNA cleavage observed following treatment with tB-OOH in L-NAME-supplemented cells. Exogenous NO also increased the DNA damage caused by tB-OOH in L-NAME-supplemented cells and this response was blunted by RR or by inhibitors of electron transport but was insensitive to peroxynitrite scavengers. We conclude that both endogenous and exogenous NO enhance the DNA cleavage generated by tB-OOH in PC12 cells. However, only endogenous NO set the bases for an involvement of peroxynitrite in this DNA-damaging response.


Subject(s)
Cyclic N-Oxides/pharmacology , DNA Damage/physiology , Imidazoles/pharmacology , NG-Nitroarginine Methyl Ester/pharmacology , Nitrates/physiology , Nitric Oxide/physiology , tert-Butylhydroperoxide/pharmacology , Animals , Calcium/metabolism , Chromans/pharmacology , DNA Damage/drug effects , DNA, Single-Stranded/drug effects , Electron Transport/drug effects , Free Radical Scavengers/pharmacology , Methacrylates , Methionine/pharmacology , Mitochondria/drug effects , Mitochondria/metabolism , Nitric Oxide Donors/pharmacology , Oxidants , PC12 Cells , Penicillamine/analogs & derivatives , Penicillamine/pharmacology , Rats , Rotenone/pharmacology , Ruthenium Red/pharmacology , S-Nitroso-N-Acetylpenicillamine , Thiazoles/pharmacology
10.
J Neurochem ; 73(4): 1667-73, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10501214

ABSTRACT

The results presented in this study indicate that the toxic response brought about by increasing concentrations of tert-butylhydroperoxide in CHP100 cells was mitigated significantly by exogenously added nitric oxide donors via a cyclic GMP-independent mechanism. In contrast with these results, endogenous nitric oxide generated by the Ca2+-mobilizing agent caffeine was found to increase hydroperoxide toxicity. Under these conditions, nitric oxide was not directly toxic to the cells. Rather, nitric oxide was found to promote the caffeine-mediated release of Ca2+ from ryanodine-sensitive Ca2+ stores via a cyclic GMP-independent mechanism. Release of the cation from ryanodine-sensitive Ca2+ stores was causally linked with the caffeine/nitric oxide-mediated enhancement of tert-butylhydroperoxide toxicity. It is concluded that endogenous and exogenous nitric oxide activate diverging signalling pathways independent of cyclic GMP formation and causing opposite effects on the toxic response evoked by tert-butylhydroperoxide in CHP100 cells.


Subject(s)
Nitric Oxide Donors/pharmacology , Nitric Oxide/physiology , Penicillamine/analogs & derivatives , Signal Transduction/physiology , tert-Butylhydroperoxide/toxicity , Caffeine/pharmacology , Calcium/metabolism , Cell Survival/drug effects , Cyclic GMP/analogs & derivatives , Cyclic GMP/metabolism , Cyclic GMP/pharmacology , Guanylate Cyclase/antagonists & inhibitors , Humans , Kinetics , Neuroblastoma , Nitric Oxide/pharmacology , Oxadiazoles/pharmacology , Penicillamine/pharmacology , Quinoxalines/pharmacology , S-Nitroso-N-Acetylpenicillamine , Signal Transduction/drug effects , Tumor Cells, Cultured
11.
J Immunol ; 163(3): 1570-6, 1999 Aug 01.
Article in English | MEDLINE | ID: mdl-10415061

ABSTRACT

Gamma delta T cells are early recruited into mycobacterial lesions. Upon microbial Ag recognition, gamma delta cells secrete cytokines and chemokines and undergo apoptosis via CD95/CD95 ligand (CD95L) interaction, possibly influencing the outcome of infection and the characteristics of the disease. In this paper we show that activated phagocytes acquire, upon challenge with Mycobacterium tuberculosis, the ability to inhibit M. tuberculosis-induced gamma delta cell apoptosis. Apoptosis protection was due to NO because it correlated with NO synthase (NOS)-2 induction and activity in scavenger cells and was abrogated by NOS inhibitors. Furthermore, the NO donor S-nitrosoacetylpenicillamine mimicked the effect of enzyme induction. NO left unaffected the expression of CD95 and CD95L, suggesting interference with an event ensuing CD95/CD95L interaction. NO was found to interfere with the intracellular accumulation of ceramide and the activation of caspases, which were involved in gamma delta T cells apoptosis after M. tuberculosis recognition. We propose that NO generated by infected macrophages determines the life span and therefore the function of lymphocytes at the infection site, thus linking innate and adaptive immunity.


Subject(s)
Apoptosis/immunology , Mycobacterium tuberculosis/immunology , Nitric Oxide Synthase/metabolism , Nitric Oxide/biosynthesis , Receptors, Antigen, T-Cell, gamma-delta/immunology , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , Animals , Antigens, Bacterial/immunology , Clone Cells , Down-Regulation/immunology , Fas Ligand Protein , Humans , Immunity, Innate , Intracellular Fluid/immunology , Ligands , Lymphocyte Activation/drug effects , Macrophage Activation/immunology , Membrane Glycoproteins/biosynthesis , Mice , Microglia , Nitric Oxide/pharmacology , Nitric Oxide/physiology , Nitric Oxide Synthase Type II , Phagocytes/immunology , Signal Transduction/immunology , T-Lymphocyte Subsets/cytology , T-Lymphocyte Subsets/microbiology , fas Receptor/biosynthesis , fas Receptor/physiology
12.
Int J Cancer ; 81(4): 573-9, 1999 May 17.
Article in English | MEDLINE | ID: mdl-10225447

ABSTRACT

Fas and Fas ligand (FasL) have been found both in lymphoid and in non-lymphoid malignancies, and are thought to play a role in the interplay between tumors and the immune system. Here we investigated Fas/FasL expression, function and intracellular signalling pathways in human melanomas. Of 5 melanoma cell lines, 3 expressed Fas at their surface, and all of them expressed FasL. FasL was functional, since it triggered Fas-induced apoptosis of human T lymphocytes clones. Conversely, cross-linking of Fas molecule with a specific monoclonal antibody failed to induce apoptosis in any of the melanomas tested, or ceramide intracellular accumulation or caspase-3 activation, pointing to an early alteration in the Fas-triggered signaling cascade. All melanomas retained the ability to undergo apoptosis induced by cytotoxic lymphocytes, which was mediated by the granule exocytosis mechanism. This suggests that melanoma cells evade immune-mediated Fas-triggered apoptosis via a selective blockade of the Fas apoptotic pathway. Cytotoxic lymphocytes, however, may circumvent tumor resistance to Fas-induced death via granzyme-mediated apoptosis, further supporting the development of immunotherapeutic strategies in the treatment of cancer.


Subject(s)
Melanoma/immunology , Membrane Glycoproteins/physiology , Signal Transduction/immunology , T-Lymphocytes, Cytotoxic/immunology , fas Receptor/physiology , Antigens, CD/immunology , Apoptosis , Cells, Cultured , Clone Cells , Coculture Techniques , Cytotoxicity, Immunologic , Fas Ligand Protein , Flow Cytometry , Humans , Interleukin-2/pharmacology , Interleukin-2/physiology , Jurkat Cells , Lymphocyte Activation , Melanoma/pathology , Membrane Glycoproteins/genetics , Receptors, Antigen, T-Cell, gamma-delta/immunology , Skin Neoplasms/immunology , Skin Neoplasms/pathology , Tumor Cells, Cultured , fas Receptor/genetics
13.
J Biol Chem ; 274(22): 15466-72, 1999 May 28.
Article in English | MEDLINE | ID: mdl-10336437

ABSTRACT

SK-N-BE neuroblastoma cell clones transfected with p75(NTR) and lacking Trk neurotrophin receptors, previously reported to undergo extensive spontaneous apoptosis and to be protected by nerve growth factor (NGF) (Bunone, G., Mariotti, A., Compagni, A., Morandi, E., and Della Valle, G. (1997) Oncogene 14, 1463-1470), are shown to exhibit (i) increased levels of the pro-apoptotic lipid metabolite ceramide and (ii) high activity of caspases, the proteases of the cell death cascade. In the p75(NTR)-expressing cells, these parameters were partially normalized by prolonged NGF treatment, which, in addition, decreased apoptosis, similar to caspase blockers. Conversely, exogenous ceramide increased caspase activity and apoptosis in both wild-type and p75(NTR)-expressing cells. A new p75(NTR)-expressing clone characterized by low spontaneous apoptosis exhibited high endogenous ceramide and low caspase levels. A marked difference between the apoptotic and resistant clones concerned the very low and high activities of nitric-oxide (NO) synthase, respectively. Protection from apoptosis by NO was confirmed by results with the NO donor S-nitrosoacetylpenicillamine and the NO-trapping agent hemoglobin. We conclude that the p75(NTR) receptor, while free of NGF, triggers a cascade leading to apoptosis; the cascade includes generation of ceramide and increased caspase activity; and the protective role of NO occurs at step(s) in between the latter events.


Subject(s)
Apoptosis/genetics , Caspases/metabolism , Ceramides/metabolism , Nitric Oxide/pharmacology , Receptors, Nerve Growth Factor/genetics , Caspase Inhibitors , Enzyme Inhibitors/pharmacology , Gene Expression Regulation/drug effects , Humans , Nerve Growth Factors/pharmacology , Neuroblastoma , Nitric Oxide Synthase/metabolism , Penicillamine/analogs & derivatives , Penicillamine/pharmacology , Receptor, Nerve Growth Factor , S-Nitroso-N-Acetylpenicillamine , Signal Transduction/drug effects , Tumor Cells, Cultured
14.
Br J Pharmacol ; 125(4): 888-94, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9831929

ABSTRACT

1. In the present work, we study the effect of NO on the proliferation and differentiation of brown fat cells in primary cultures. 2. Brown fat precursor cells isolated from rat brown adipose tissue were cultured for 8 days until confluence and treated daily with the NO donating agents, S-nitroso-acetyl penicillamine (SNAP) or S-nitroso-L-glutathione (GSNO). Both agents (300 microM) decreased cell proliferation approximately 8 fold on day 8. The inhibitory effect of NO was unlikely to be due to cytotoxicity since (i) cells never completely lost their proliferation capacity even after 8 days of exposure to repeated additions of SNAP or GSNO, and (ii) the inhibitory effect was reversible after removal of the media containing NO donors. 3. Daily treatment with nitric oxide synthase inhibitors, such as NG-nitro-L-arginine methyl ester (L-NAME, 300 microM), led to the stimulation of cell proliferation by 44+/-5%, n=3, suggesting that NO, endogenously produced in brown adipocytes, may be involved in modulating cell growth. 4. Daily treatment with both SNAP or GSNO induced significant mitochondriogenesis, measured as the mitochondrial conversion of 3-[4,5-dimethylthiazol-2-yl-]-2,5-diphenyl tetrazolium bromide (MTT) to formazan, whilst daily treatment with L-NAME was without effect. 5. The inhibition of cell proliferation by NO donors was accompanied by the expression of two genes coding for peroxisome proliferator activated receptor-gamma and uncoupling protein-1, which are upregulated during differentiation. 6. Increasing cyclic GMP in cells by 8-bromo-cyclic GMP (100-1000 microM) did not reproduce the observed NO effects on either cell number or gene expression. On the other hand, chronic treatment with the inhibitor of the NO-stimulated guanylyl cyclase, 1H-[1,2,4]oxadiazole[4,3-a]quinoxalin-1-one (ODQ), reduced the expression of peroxisome proliferator activated receptor-gamma and uncoupling protein-1.


Subject(s)
Adipose Tissue, Brown/drug effects , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide/pharmacology , Animals , Base Sequence , Cell Differentiation/drug effects , Cell Division/drug effects , Cells, Cultured , Cyclic GMP/analogs & derivatives , Cyclic GMP/pharmacology , Glutathione/analogs & derivatives , Glutathione/pharmacology , Male , Molecular Sequence Data , NG-Nitroarginine Methyl Ester/pharmacology , Nitroso Compounds/pharmacology , Penicillamine/analogs & derivatives , Penicillamine/pharmacology , Radioimmunoprecipitation Assay , Rats , Rats, Sprague-Dawley , S-Nitrosoglutathione , Time Factors
15.
Br J Pharmacol ; 125(5): 1074-80, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9846647

ABSTRACT

1. Caffeine (Cf) enhances the DNA cleavage induced by tert-butylhydroperoxide (tB-OOH) in U937 cells via a mechanism involving Ca2+-dependent mitochondrial formation of DNA-damaging species (Guidarelli et al., 1997b). Nitric oxide (NO) is not involved in this process since U937 cells do not express the constitutive nitric oxide synthase (cNOS). 2. Treatment with the NO donors S-nitroso-N-acetyl-penicillamine (SNAP, 10 microM), or S-nitrosoglutathione (GSNO, 300 microM), however, potentiated the DNA strand scission induced by 200 microM tB-OOH. The DNA lesions generated by tB-OOH alone, or combined with SNAP, were repaired with superimposable kinetics and were insensitive to anti-oxidants and peroxynitrite scavengers but suppressed by iron chelators. 3. SNAP or GSNO did not cause mitochondrial Ca2+ accumulation but their enhancing effects on the tB-OOH-induced DNA strand scission were prevented by ruthenium red, an inhibitor of the calcium uniporter of mitochondria. Furthermore, the enhancing effects of both SNAP and GSNO were identical to and not additive with those promoted by the Ca2+-mobilizing agents Cf or ATP. 4. The SNAP- or GSNO-mediated enhancement of the tB-OOH-induced DNA cleavage was abolished by the respiratory chain inhibitors rotenone and myxothiazol and was not apparent in respiration-deficient cells. 5. It is concluded that, in cells which do not express the enzyme cNOS, exogenous NO enhances the accumulation of DNA single strand breaks induced by tB-OOH via a mechanism involving inhibition of complex III.


Subject(s)
DNA Damage , DNA, Single-Stranded/drug effects , Nitric Oxide/metabolism , tert-Butylhydroperoxide/pharmacology , Caffeine/pharmacology , Calcium/metabolism , Cytochromes c1/metabolism , DNA, Single-Stranded/metabolism , Electron Transport , Humans , Mitochondria/metabolism , NAD(P)H Dehydrogenase (Quinone)/metabolism , Nitrates/metabolism , Nitric Oxide/pharmacology , Nitric Oxide Synthase/biosynthesis , Nitric Oxide Synthase Type I , Penicillamine/analogs & derivatives , Penicillamine/pharmacology , Tumor Cells, Cultured , U937 Cells , Ubiquinone/metabolism
16.
Eur J Immunol ; 28(6): 1798-806, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9645360

ABSTRACT

Vgamma9/Vdelta2+ T cells specifically recognize Mycobacterium tuberculosis in vitro and are precociously recruited in early mycobacterial lesions. Even if gammadelta T cells are only fortuitously detected in granulomas or bronchoalveolar lavages of patients with active pulmonary tuberculosis, a role in shaping the mature alphabeta T cell response against M. tuberculosis is substantiated. Here we provide a molecular explanation for this paradox: the engagement of the gammadelta TCR by mycobacterial antigens induced the expression of CD95 ligand (CD95L) by chronically activated CD95+/CD95L- gammadelta T lymphocytes. The receptor was functional, as CD95/CD95L interaction triggered the bystander death of CD95+ cells by apoptosis. Cell death was abolished by CD95-blocking antibodies. The transient accumulation at the site of infection of CD95L+ gammadelta lymphocytes, capable of interacting with CD95+ leukocytes attracted by the response towards the pathogen, may determine the characteristics of the ensuing granulomatous disease.


Subject(s)
Apoptosis , Membrane Glycoproteins/immunology , Mycobacterium tuberculosis/immunology , Receptors, Antigen, T-Cell, gamma-delta/immunology , T-Lymphocytes/immunology , fas Receptor/immunology , Cell Line , Fas Ligand Protein , Humans , T-Lymphocytes/microbiology
17.
J Pharmacol Exp Ther ; 283(1): 66-74, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9336309

ABSTRACT

Treatment of U937 cells with a sublethal albeit DNA-damaging concentration of tert-butylhydroperoxide (tB-OOH) enhanced mitochondrial Ca++ uptake and ruthenium red (RR), a polycation that inhibits the calcium uniporter of mitochondria, significantly reduced the extent of DNA cleavage generated by the hydroperoxide. Release of Ca++ from the ryanodine(Ry)/caffeine(Cf)-sensitive stores further increased mitochondrial Ca++ uptake and elicited a parallel enhancement in DNA strand scission induced by tB-OOH that was prevented by both Ry and RR. DNA damage caused by tB-OOH alone or associated with either Cf or RR was prevented by iron chelators, insensitive to antioxidants and repaired with kinetics superimposable with those observed after treatment with H2O2. Cf enhanced the DNA-damaging effects of tB-OOH in permeabilized cells as well, and similar effects were observed upon addition of CaCl2. Cf did not further increase the formation of DNA lesions elicited by tB-OOH in the presence of CaCl2. The enhancing effects of Cf were prevented by RR and ryanodine, whereas those mediated by exogenous calcium were prevented only by RR. DNA strand scission caused by tB-OOH alone or associated with Cf in the permeabilized cell system was severely inhibited by ethylene glycol-bis(beta-aminoethyl ether)-N, N,N',N'-tetraacetic acid. The mechanism(s) whereby Ca++ promotes the mitochondrial formation of species that will ultimately result in the formation of DNA lesions was subsequently analyzed using intact as well as permeabilized cells. Hydrogen peroxide was identified to be one of these species.


Subject(s)
Calcium/metabolism , DNA Damage , DNA, Single-Stranded/drug effects , Mitochondria/metabolism , Peroxides/toxicity , Caffeine/pharmacology , Humans , Hydrogen Peroxide/toxicity , Tumor Cells, Cultured , tert-Butylhydroperoxide
18.
J Biol Chem ; 272(37): 23211-5, 1997 Sep 12.
Article in English | MEDLINE | ID: mdl-9287328

ABSTRACT

Gammadelta T lymphocytes play an important early role in the defense against pathogens. Their function is terminated by acquisition of susceptibility to CD95-triggered apoptosis. Here we show that the regulation of this process depends on the activity of the endothelial NO synthase expressed by gammadelta T lymphocytes, which is modulated in an activation-dependent way. The effects of nitric oxide thus generated, mediated via cGMP generation, are exerted at at least two sites along the CD95 signaling cascade: one at, or upstream, and the other downstream of ceramide generation. At either site, nitric oxide/cGMP action is sufficient for protection from apoptosis. The effect of NO is selective for apoptosis induced by CD95 cross-linking, since it does not affect apoptotic program triggered by other stimuli. The evidence here reported demonstrates a new physiological role for nitric oxide, acting as a survival factor for T lymphocytes.


Subject(s)
Apoptosis , Nitric Oxide/metabolism , Receptors, Antigen, T-Cell, gamma-delta , T-Lymphocyte Subsets/immunology , fas Receptor/metabolism , Calcium/metabolism , Ceramides/metabolism , Clone Cells , Humans , Isoenzymes/metabolism , Models, Immunological , Nitric Oxide Synthase/metabolism , Signal Transduction , T-Lymphocyte Subsets/metabolism
19.
Br J Pharmacol ; 122(4): 687-97, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9375965

ABSTRACT

1. The role of nitric oxide (NO) in the control of cell growth is controversial since both stimulation and (more often) inhibition have been demonstrated in various cell types. In order to reinvestigate the problem and identify the sites of NO action, we have employed murine NIH-3T3 fibroblasts overexpressing epidermal growth factor (EGF) receptors. 2. The effects of four structurally-unrelated NO donors: S-nitroso-N-acetyl penicillamine, S-nitroso-L-glutathione, 3-morpholinosydnonimine and isosorbide dinitrate (0.01-3 mM) on EGF (10 nM)-stimulated cell growth were estimated by both thymidine incorporation and the colorimetric MTT assay, while those of a messenger generated in response to NO, cyclic GMP, were revealed by the use of 8-Br cyclic GMP (0.01-3 mM) as well as of blockers of guanylyl cyclase and cyclic GMP-dependent kinase I. 3. Studies were focused on: (i) multiple signalling events, including receptor-induced tyrosine phosphorylations, phosphorylation of mitogen-activated protein kinase, activation of the AP-1 transcription complex and deoxyribonucleotide synthesis; (ii) the progression through the cell cycle, dissected out by the use of staurosporine (1 nM), lovastatin (10 microM), mimosine (200 microM), hydroxyurea (1 mM) and nocodazole (1.5 microM). 4. NO was found to have no effects on the phosphorylation events of the growth factor cascade. In contrast, later processes were modified by the messenger but with opposite effects. 5. A cyclic GMP-dependent stimulation of growth was shown to be sustained in part by the activation of the AP-1 transcription complex, while a predominant, cyclic GMP-independent inhibition was found to be mediated by both the negative regulation of ribonucleotide reductase and the marked slowing down of the cell cycle occurring at early and late G1 and during the S phase. 6. Although multiple and apparently conflicting, the effects of NO here described could work coordinately in a general programme of cell growth regulation. In particular, the cyclic GMP-dependent actions might function as rapid modulatory events, while the effects on cell cycle might operate collectively as a multi-switch process whenever growth inhibition is required.


Subject(s)
Cell Cycle/drug effects , Cell Division/drug effects , Cyclic GMP/pharmacology , Nitric Oxide/pharmacology , Transcription Factor AP-1/metabolism , 3T3 Cells , Animals , Epidermal Growth Factor/pharmacology , ErbB Receptors/genetics , Humans , Mice , Recombinant Proteins/genetics , Signal Transduction
20.
Exp Cell Res ; 237(1): 176-85, 1997 Nov 25.
Article in English | MEDLINE | ID: mdl-9417880

ABSTRACT

The NADH-linked substrates pyruvate, L-glutamine, and beta-hydroxybutyrate, while enhancing the rate of oxygen consumption, also increased the formation of DNA single-strand breaks induced by tert-butylhydroperoxide in intact U937 cells. A cause-effect relationship between these two parameters was established by showing that: (a) rotenone, an inhibitor of complex I, abolished respiration and prevented the enhancement of the DNA-damaging response under all the above circumstances; (b) the membrane-impermeant, complex I-activating substrate L-malate gave similar results in permeabilized cells; and (c) none of the NADH-linked substrates affected the DNA-damaging response to tert-butylhydroperoxide in respiration-deficient cells. Stimulation of electron transport potentiated the DNA-cleaving ability of tert-butylhydroperoxide via a process involving enforced mitochondrial calcium accumulation in the absence of a discernible elevation in the cytosolic concentration of free Ca2+. Finally, mitochondrial calcium was found to promote the mitochondrial formation of DNA-damaging levels of hydrogen peroxide. In conclusion, the data herein presented define a previously unexpected role of respiratory substrates in the control of the deleterious effects of an organic hydroperoxide at the level of genomic DNA. The enhanced DNA cleavage mediated by NADH-linked substrates in response to tert-butylhydroperoxide would appear to depend on a sequence of events involving stimulation of electron transport, mitochondrial accumulation of Ca2+, and mitochondrial formation of DNA-damaging levels of hydrogen peroxide via a Ca(2+)-dependent process.


Subject(s)
Calcium/metabolism , DNA Damage , DNA, Single-Stranded/drug effects , Mitochondria/metabolism , Oxygen Consumption/physiology , Peroxides/toxicity , Rotenone/pharmacology , 3-Hydroxybutyric Acid , Caffeine/pharmacology , Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone/pharmacology , Catalase/pharmacology , Electron Transport/drug effects , Glucose/pharmacology , Glutamine/pharmacology , Humans , Hydrogen Peroxide/metabolism , Hydrogen Peroxide/toxicity , Hydroxybutyrates/pharmacology , Kinetics , Leukemia, Myeloid , Mitochondria/drug effects , NAD/metabolism , Oxygen Consumption/drug effects , Pyruvates/pharmacology , Reactive Oxygen Species , Tumor Cells, Cultured , tert-Butylhydroperoxide
SELECTION OF CITATIONS
SEARCH DETAIL
...